Sunbeam Capital Management’s AbbVie ABBV Stock Holding History

Sunbeam Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.15M	Buy	4,574 +127	+3%	+$27.3K	0.53%	40
2026 Q1	$967K	Buy	4,447 +16	+0.4%	+$3.55K	0.55%	35
2025 Q4	$1.01M	Sell	4,431 -18	-0.4%	-$4.1K	0.6%	32
2025 Q3	$1.03M	Buy	4,449 +205	+5%	+$41.7K	0.64%	30
2025 Q2	$788K	Buy	4,244 +248	+6%	+$46.1K	0.6%	36
2025 Q1	$837K	Buy	3,996 +104	+3%	+$20.2K	0.8%	30
2024 Q4	$692K	Buy	+3,892	New	+$716K	0.64%	32

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Sunbeam Capital Management's ABBV Position: Q2 2026 in Review

Sunbeam Capital Management increased its AbbVie (ABBV) stake by 2.9% in Q2 2026, buying an estimated $27.3K and bringing the position to 4,574 shares worth $1.15M. The position accounts for 0.53% of the portfolio, ranked #40.

Sunbeam Capital Management first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 2,119 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Sunbeam Capital Management held 4,574 shares of AbbVie worth $1.15M as of Q2 2026.
Sunbeam Capital Management bought 127 AbbVie shares in Q2 2026, an estimated $27.3K.
AbbVie made up 0.53% of Sunbeam Capital Management's portfolio in Q2 2026, its #40 holding.
Sunbeam Capital Management first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
2,119 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Sunbeam Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.